Section 11-45-167 - Training for uptake, dilution, or excretion studies Except as provided in sections 11-45-169 and 11-45-170, the licensee shall require the authorized user of a radiopharmaceutical listed in section 11-45-155 to be a physician who:
(1) Is certified in: (A) Nuclear medicine by the American Board of Nuclear Medicine; or(B) Diagnostic radiology by the American Board of Radiology; or(C) Diagnostic radiology or radiology by the American Osteopathic Board of Radiology; or(D) Nuclear medicine by the American Osteopathic Board of Nuclear Medicine; or(E) Nuclear medicine by the Royal College of Physicians and Surgeons of Canada; or(2) Has successfully completed a six-month training program in nuclear medicine as part of a training program that has been approved by the Accreditation Council for Graduate Medical Education and that included classroom and laboratory training, work experience, and supervised clinical experience.[Eff 11/12/99] (Auth: HRS §§ 321-10, 321-11, 321-71) (Imp: HRS §§ 321-1, 321-11(21), 321-71)